Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel
CDSMP-IL
Implementation of a Self-Management Support Program Among People With Kidney Transplant and Cancer Survivors in Israel: Testing Feasibility and Effects
2 other identifiers
interventional
45
1 country
1
Brief Summary
This study explores an intervention to support people in Israel who are living with chronic health conditions such as cancer or after kidney transplantation. It focuses on a well-known international program called the Chronic Disease Self-Management Program (CDSMP), which was developed at Stanford University. The program helps individuals build confidence and skills to better manage their health, feel more in control, and improve their day-to-day quality of life. Participants will take part in a six-week group program, delivered online, where they will learn practical strategies for managing symptoms like fatigue or pain, setting achievable health goals, communicating effectively with healthcare professionals, and staying active and engaged. The sessions are guided by trained facilitators and include support from others facing similar health challenges. The study will involve surveys before and after the program, as well as a follow-up six months later, to understand how the program may have helped participants. Some participants will also be invited to share their experiences in small discussion groups. By testing this program in Israel, the researchers hope to learn how it can be adapted and offered more widely to help others living with chronic conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 28, 2027
April 29, 2026
April 1, 2026
2 years
September 25, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Patient Activation Measure (PAM-13)
The Patient Activation Measure (PAM-13) is a validated self-report questionnaire that assesses individuals' knowledge, skills, and confidence in managing their health. Higher scores reflect greater activation and self-management ability.
Baseline, immediately post-intervention, 6-month follow-up
health-related behaviors
Assessed using a custom self-report questionnaire developed by the research team, covering physical activity, nutrition, medication adherence, and use of health services.
Baseline, immediately post-intervention, 6-month follow-up
chronic disease symptom burden
Evaluated using the Self-Management Resource Center (SMRC) symptom survey, which includes ratings of fatigue, pain, emotional distress, sleep, depression, anxiety, and social isolation.
Baseline, immediately post-intervention, 6-month follow-up
health-related quality of life (EQ-5D)
Baseline, immediately post-intervention, 6-month follow-up
Measured by the EQ-5D instrument, which assesses five dimensions of functioning and includes a global self-rated health visual analogue scale.
Secondary Outcomes (3)
Themes from focus group analysis regarding participant experience
through study completion, an average of 6-month
Perceived facilitators and barriers to self-management
through study completion, an average of 6-month
Participant suggestions for improving the CDSMP
through study completion, an average of 1 year
Study Arms (1)
CDSMP Group
EXPERIMENTALParticipants with chronic diseases (kidney transplant recipients or cancer survivors) will participate in the Chronic Disease Self-Management Program (CDSMP), a six-week online group intervention
Interventions
A structured, peer-led, six-week online intervention developed at Stanford University to enhance self-management skills in individuals with chronic conditions. Sessions include action planning, symptom management, medication adherence, healthy behaviors, and emotional coping.
Eligibility Criteria
You may qualify if:
- Age 21 years or older
- Diagnosed with at least one chronic disease (as documented in the medical record)
- Community-dwelling
- Fluent in Hebrew
You may not qualify if:
- Documented cognitive impairment
- Diagnosis of major depression or other psychiatric disorder (based on self-report or medical records)
- Hospitalization in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Galit Yogev-Seligmann
University of Haifa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- researcher, Senior Lecturer
Study Record Dates
First Submitted
September 25, 2025
First Posted
January 26, 2026
Study Start
February 1, 2025
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
March 28, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy considerations and the sensitive nature of the self-reported health and behavioral data collected. No plans for data sharing have been established at this time.